Grantham, Mayo, Van Otterloo & Co (GMO)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,267	Closed	-$241K	–	633
2025 Q2	$241K	Sell	2,267 -5,854	-72%	-$636K	﹤0.01%	580
2025 Q1	$1.01M	Sell	8,121 -16,994	-68%	-$2.22M	﹤0.01%	457
2024 Q4	$3.09M	Buy	25,115 +22,108	+735%	+$2.61M	0.01%	341
2024 Q3	$335K	Sell	3,007 -5,324	-64%	-$583K	﹤0.01%	518
2024 Q2	$889K	Sell	8,331 -185,869	-96%	-$20.4M	﹤0.01%	405
2024 Q1	$23.4M	Sell	194,200 -13,558	-7%	-$1.66M	0.09%	169
2023 Q4	$25.6M	Buy	207,758 +25,076	+14%	+$3.13M	0.11%	139
2023 Q3	$23.6M	Sell	182,682 -1,295	-0.7%	-$173K	0.11%	159
2023 Q2	$22.8M	Sell	183,977 -44,723	-20%	-$6.02M	0.11%	169
2023 Q1	$33.5M	Sell	228,700 -2,900	-1%	-$429K	0.17%	124
2022 Q4	$36.9M	Buy	231,600 +29,600	+15%	+$4.34M	0.2%	106
2022 Q3	$26.9M	Buy	202,000 +5,100	+3%	+$775K	0.16%	132
2022 Q2	$30.7M	Sell	196,900 -4,800	-2%	-$739K	0.17%	119
2022 Q1	$31.4M	Buy	201,700 +22,100	+12%	+$3.21M	0.15%	121
2021 Q4	$22.9M	Buy	179,600 +3,100	+2%	+$407K	0.11%	153
2021 Q3	$23M	Buy	176,500 +28,600	+19%	+$4.32M	0.11%	150
2021 Q2	$26.3M	Buy	147,900 +30,100	+26%	+$5.21M	0.13%	135
2021 Q1	$19.4M	Buy	117,800 +27,600	+31%	+$4.54M	0.11%	154
2020 Q4	$14.9M	Buy	+90,200	New	+$13.4M	0.09%	148